New Haven biotech Alexion Pharmaceuticals Inc. will partner with a startup in the Netherlands on a new drug to treat degenerative brain disorders. Alexion on Monday announced a deal with ...
As Kira Pharma shepherds two more programs toward the clinic, the complement-focused biotech is bolstering its leadership team with a trio of biopharma veterans, including a pair of Alexion alums. Its ...
Alexion Pharmaceuticals, Inc has announced the submission of a biologics license application (BLA) to the US Food and Drug Administration (FDA) for approval of ALXN1210, the company’s investigational ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する